Discover and read the best of Twitter Threads about #MedicalMycology
Most recents (1)
Next up, the “What’s Hot in Antifungals?” session by the ever-insightful @DavidAndes, @IDPharmacist, and Dr. Sharon Chen. There’s a lot of development in the antifungal sphere so strap in! @MSG_ERC @GermHunterMD @FungalDoc @GRThompson @IDSA @SIDPharm 1/
So what are the current gaps in available antifungals? Notable gaps include parenteral only, PK distribution to sanctuary sites/urine, toxicity, DDIs, and MDR pathogens (I’m looking at you, the fungus formerly known as S. prolificans). 2/
The novel antifungal pipeline in all of its glory, broken down into similar MOA with improvement in features vs. novel targets/mechanisms.
Some great reviews of newer agents for interested parties:
doi.org/10.1093/ofid/o…
doi.org/10.3390/jof601…
doi.org/10.3390/jof204…
3/
Some great reviews of newer agents for interested parties:
doi.org/10.1093/ofid/o…
doi.org/10.3390/jof601…
doi.org/10.3390/jof204…
3/
